[Federal Register Volume 88, Number 56 (Thursday, March 23, 2023)]
[Notices]
[Pages 17586-17587]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-05984]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Menopause and Optimizing Midlife Health of Women

AGENCY: National Institutes of Health, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This symposium is sponsored by the NIH Office of Research on 
Women's Health (ORWH), the title of this year's symposium is 
``Menopause and Optimizing Midlife Health of Women.'' The symposium 
will discuss menopausal transition, accumulation of morbidity after 
menopause, menopause in special populations, social determinants of 
health, menopausal hormonal therapy, and interventions to promote 
healthy aging.

DATES: The meeting will be held on May 16, 2023, from 10 a.m. to 5 p.m.

ADDRESSES: The meeting will be virtual. Registration is available at 
https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA. The 
meeting is viewable on NIH Videocast at https://videocast.nih.gov/watch=49307; no registration required.

FOR FURTHER INFORMATION CONTACT: For information concerning this 
meeting, see the ORWH website, https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium, or contact Dr. Sarah Temkin, 
Associate Director for Clinical Research, Office of Research on Women's 
Health, 6707 Democracy Boulevard, Suite 400, Bethesda, MD 20817, 
telephone: 301-402-1770; email: [email protected].

SUPPLEMENTARY INFORMATION: This Notice is in accordance with 42 U.S.C. 
287d, of the Public Health Service Act, as amended. The 7th Annual 
Vivian W. Pinn Symposium honors the first full-

[[Page 17587]]

time director of ORWH, Dr. Vivian Pinn, and is held during National 
Women's Health Week. This event serves as a critical forum for experts 
across sectors to communicate and collaborate for the advancement of 
women's health.
    Providing the keynote address, ``Menopausal Hormone Therapy: 30 
Years of Lessons from the Women's Health Initiative,'' is JoAnn Manson, 
M.D., Professor of Medicine at Harvard Medical School and Chief of the 
Division of Preventive Medicine, Department of Medicine at Brigham and 
Women's Hospital. A patient advocacy panel will discuss the patient 
perspective of menopause.
    The objectives of the symposium are to:
     Familiarize attendees with state of the science related to 
our understanding of risk factors and mechanisms that lead to 
reproductive aging.
     Understand women's unique morbidity and multimorbidity 
burden to identify points of intervention.
     Identify the needs of populations at risk for iatrogenic 
menopause (patients with germline inherited cancer risk) and early or 
complex menopausal symptoms (patients living with HIV, chronic 
conditions, and cancer).
     Identify priorities to address unmet environmental and 
other exposures as it relates to menopausal transition and symptoms in 
diverse populations of women.
     Understand current recommendations on menopausal hormone 
therapy prescribing including when to start and stop, and formulations 
and durations of use.
    Interested individuals can register at: https://nih.zoomgov.com/webinar/register/WN_YMa1r3QbSsiQ8scHfc4ixA. More information about the 
speakers and agenda can be found at https://orwh.od.nih.gov/about/newsroom/events/7th-annual-vivian-w-pinn-symposium. This event is free.

    Dated: March 17, 2023.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2023-05984 Filed 3-22-23; 8:45 am]
BILLING CODE 4140-01-P